Search Results - "Jaben, Korey"

Isolated Abducens Nerve Palsy Following Pembrolizumab by Jaben, Korey A, Francis, Jasmine H, Shoushtari, Alexander N, Abramson, David H

“…Pembrolizumab is a checkpoint inhibitor targeting the programmed cell death 1 receptor of lymphocytes and is used in the treatment of solid tumours including…”
Get full text

Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors by Canestraro, Julia, Jaben, Korey A., Wolchok, Jedd D., Abramson, David H., Francis, Jasmine H.

“…To report asymptomatic progressive fundus depigmentation and choroidal thinning in the absence of intraocular inflammation in a patient treated with checkpoint…”
Get full text

Lacrimal sac adenocarcinoma managed with androgen deprivation by Abramson, David H., Fallon, Julia, Biran, Noa, Francis, Jasmine H., Jaben, Korey, Oh, William K.

“…To describe a case of primary lacrimal sac adenocarcinoma treated primarily with androgen deprivation therapy (ADT) with good clinic response. An 82-year-old…”
Get full text

Immune Checkpoint Inhibitor-Associated Optic Neuritis by Francis, Jasmine H., Jaben, Korey, Santomasso, Bianca D., Canestraro, Julia, Abramson, David H., Chapman, Paul B., Berkenstock, Meghan, Aronow, Mary E.

“…The three classes of immune checkpoint inhibitors can be associated with optic neuritis, which typically presents with bilateral, painless visual decline…”
Get full text

Reply by Francis, Jasmine H., Jaben, Korey, Santomasso, Bianca D., Canestraro, Julia, Abramson, David H., Berkenstock, Meghan, Aronow, Mary E.

Get full text

Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading by Francis, Jasmine H, Berry, Duncan, Abramson, David H, Barker, Christopher A, Bergstrom, Chris, Demirci, Hakan, Engelbert, Michael, Grossniklaus, Hans, Hubbard, Baker, Iacob, Codrin E, Jaben, Korey, Kurli, Madhavi, Postow, Michael A, Wolchok, Jedd D, Kim, Ivana K, Wells, Jill R

“…Cutaneous melanoma metastatic to the vitreous is very rare. This study investigated the clinical findings, treatment, and outcome of patients with metastatic…”
Get full text

Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition by Francis, Jasmine H., Berry, Duncan, Abramson, David H., Barker, Christopher A., Bergstrom, Chris, Demirci, Hakan, Engelbert, Michael, Grossniklaus, Hans, Hubbard, Baker, Iacob, Codrin E., Jaben, Korey, Kurli, Madhavi, Postow, Michael A., Wolchok, Jedd D., Kim, Ivana K., Wells, Jill R.

“…Cutaneous melanoma metastatic to the vitreous is very rare. This study investigated the clinical findings, treatment, and outcome of patients with metastatic…”
Get full text

Reply by Francis, Jasmine H, Jaben, Korey, Santomasso, Bianca D, Canestraro, Julia, Abramson, David H, Berkenstock, Meghan, Aronow, Mary E

Get full text

MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR Variants by Francis, Jasmine H., Diamond, Eli L., Chi, Ping, Jaben, Korey, Hyman, David M., Abramson, David H.

“…Background: Central retinal vein occlusion (CRVO) is a visually threatening event that has rarely been observed in patients taking MEK1/2 inhibitors and that…”
Get full text

Dexamethasone and methylprednisolone do not inhibit neuritic outgrowth while inhibiting outgrowth of fibroblasts from spiral ganglion explants by Furze, Alexis, Kralick, Deanna, Vakharia, Anand, Jaben, Korey, Graves, Reid, Adil, Eelam, Eshraghi, Adrien A., Balkany, Thomas J., Van de water, Thomas R.

“…Conclusion. Dexamethasone and methylprednisolone do not inhibit neuritic outgrowth while inhibiting fibroblastic outgrowth from spiral ganglion micro-explants…”
Get full text

Lacrimal sac adenocarcinoma managed with androgen deprivation by Abramson, David H, Fallon, Julia, Biran, Noa, Francis, Jasmine H, Jaben, Korey, Oh, William K

“…PURPOSETo describe a case of primary lacrimal sac adenocarcinoma treated primarily with androgen deprivation therapy (ADT) with good clinic response…”
Get full text

Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors by Canestraro, Julia, Jaben, Korey A, Wolchok, Jedd D, Abramson, David H, Francis, Jasmine H

“…PURPOSETo report asymptomatic progressive fundus depigmentation and choroidal thinning in the absence of intraocular inflammation in a patient treated with…”
Get full text

Isolated Abducens Nerve Palsy Following Pembrolizumab by Jaben, Korey A, Francis, Jasmine H, Shoushtari, Alexander N, Abramson, David H

Get full text

Isolated Abducens Nerve Palsy Following Pembrolizumab by Jaben, Korey A., Francis, Jasmine H., Shoushtari, Alexander N., Abramson, David H.

“…Pembrolizumab is a checkpoint inhibitor targeting the programmed cell death 1 receptor of lymphocytes and is used in the treatment of solid tumours including…”
Get full text

MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR Variants by Francis, Jasmine H, Diamond, Eli L, Chi, Ping, Jaben, Korey, Hyman, David M, Abramson, David H

“…BACKGROUNDCentral retinal vein occlusion (CRVO) is a visually threatening event that has rarely been observed in patients taking MEK1/2 inhibitors and that may…”
Get full text